持続的腎代替療法機器（CRRT）の世界市場：洞察、競合情勢、市場予測：2030年

世界の持続的腎代替療法（CRRT）機器の市場規模は、2023年に12億5,000万米ドルとなりました。同市場は、2024年から2030年の予測期間中に7.39％のCAGRで拡大し、2030年には19億2,000万米ドルに達すると予測されています。CRRT機器の需要は、世界中で急性腎不全や急性腎障害（AKI）の有病率が上昇していること、敗血症の発生率の増加とともにAKIを発症したICU患者の負担が増加していること、製品ラインにおける大幅な技術進歩が主な原因です。断続的な血液浄化システムに対するCRRTの臨床的優位性も、CRRT機器市場の顕著な促進要因です。

急性腎障害（AKI）は、すべての入院患者にとって最も一般的な重篤な合併症の1つであり、その発生率は入院患者、特に集中治療室の患者で増加しています。さらに、基礎疾患である慢性腎臓病がAKIの危険因子であることも認識されています。また、LANCET 2020に掲載された研究によると、2017年には全段階CKDの症例が6億9,750万件記録され、約120万人がこの適応で死亡しています。慢性腎障害の有病率の上昇とそれに伴う死亡は、CRRT機器による適切かつタイムリーな治療によって減少した可能性があります。CRRT機器は、AKIに罹患し、血行動態が不安定な重症患者に対して、24時間かけてゆっくりと体液と尿毒症毒素を除去し、きれいな血液を体内に戻すことで腎臓をサポートします。したがって、CRRTの世界市場の成長に寄与しています。

さらに、持続的腎代替療法の登場以来、主に高浸透血液濾過と高容量透過性からなる様々な技術進歩も、世界のCRRT市場を押し上げると予想されています。

現在、メーカーは、CRRT処置中に安全で信頼性の高い性能を発揮する精密な装置を開発しています。また、簡単に性能を発揮できるように、これらの機器には使いやすいインターフェースが装備されています。例えば、最近2022年には、バクスターが次世代CRRTプラットフォームの最新バージョンであるPrisMax 2の発売を発表しました。PrisMax 2システムは、同社のTrueVueデジタルヘルスポートフォリオに含まれる新たなソリューションを搭載しており、持続的腎代替療法（CRRT）やその他の臓器支持療法の提供を簡素化すると同時に、集中治療室（ICU）特有の需要に対応できる柔軟性を病院に提供するよう設計されています。このような要因が、世界のCRRT機器市場の拡大に寄与しています。

当レポートでは、世界の持続的腎代替療法機器（CRRT）市場について調査し、市場の概要とともに、製品タイプ別、モダリティ別、患者別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 持続的腎代替療法機器（CRRT）市場レポートのイントロダクション

第2章 持続的腎代替療法機器（CRRT）市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 持続的腎代替療法機器（CRRT）市場の主な要因分析

• 持続的腎代替療法機器（CRRT）市場の促進要因
• 持続的腎代替療法機器（CRRT）市場の抑制要因と課題
• 持続的腎代替療法機器（CRRT）市場の機会

第5章 持続的腎代替療法機器（CRRT）におけるポーターのファイブフォース分析

第6章 持続的腎代替療法機器（CRRT）市場の概要

• 製品タイプ別
• モダリティ別
• 患者別
• エンドユーザー別
• 地域別

第7章 持続的腎代替療法機器（CRRT）の企業と製品概要

• Baxter International Inc.
• Fresenius Medical Care AG &Co. KGaA
• NIKKISO CO., LTD.
• B. Braun Melsungen AG
• Asahi Kasei Corporation
• Infomed SA
• Medtronic
• NxStage Medical, Inc.
• Medica S.p.A.
• SWS Hemodialysis Care Co., Ltd.
• Dialco Medical Inc.
• Anjue Medical Equipment Co. Ltd.
• Medica S.p.A.
• Jiangxi Sanxin Medtec Co. Ltd.

第8章 KOL の見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: CRRT Machines Market in Global (2021-2030)
• Table 3: CRRT Machines Market in Global by Product Type (2021-2030)
• Table 4: CRRT Machines Market in Global by Modality (2021-2030)
• Table 5: CRRT Machines Market in Global by Patient (2021-2030)
• Table 6: CRRT Machines Market in Global by End-User (2021-2030)
• Table 7: CRRT Machines Market in Global by Geography (2021-2030)
• Table 8: CRRT Machines Market in North America (2021-2030)
• Table 9: CRRT Machines Market in the US (2021-2030)
• Table 10: CRRT Machines Market in Canada (2021-2030)
• Table 11: CRRT Machines Market in Mexico (2021-2030)
• Table 12: CRRT Machines Market in Europe (2021-2030)
• Table 13: CRRT Machines Market in France (2021-2030)
• Table 14: CRRT Machines Market in Germany (2021-2030)
• Table 15: CRRT Machines Market in the United Kingdom (2021-2030)
• Table 16: CRRT Machines Market in Italy (2021-2030)
• Table 17: CRRT Machines Market in Spain (2021-2030)
• Table 18: CRRT Machines Market in Rest of Europe (2021-2030)
• Table 19: CRRT Machines Market in Asia-Pacific (2021-2030)
• Table 20: CRRT Machines Market in China (2021-2030)
• Table 21: CRRT Machines Market in Japan (2021-2030)
• Table 22: CRRT Machines Market in India (2021-2030)
• Table 23: CRRT Machines Market in Australia (2021-2030)
• Table 24: CRRT Machines Market in South Korea (2021-2030)
• Table 25: CRRT Machines Market in Rest of Asia-Pacific (2021-2030)
• Table 26: CRRT Machines Market in the Rest of the World (2021-2030)
• Table 27: CRRT Machines Market in the Middle East (2021-2030)
• Table 28: CRRT Machines Market in Africa (2021-2030)
• Table 29: CRRT Machines Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: CRRT Machines Market in Global (2021-2030)
• Figure 3: CRRT Machines Market in Global by Product Type (2021-2030)
• Figure 4: CRRT Machines Market in Global by Modality (2021-2030)
• Figure 5: CRRT Machines Market in Global by Patient (2021-2030)
• Figure 6: CRRT Machines Market in Global by End-User (2021-2030)
• Figure 7: CRRT Machines Market in Global by Geography (2021-2030)
• Figure 8: CRRT Machines Market in North America (2021-2030)
• Figure 9: CRRT Machines Market in the US (2021-2030)
• Figure 10: CRRT Machines Market in Canada (2021-2030)
• Figure 11: CRRT Machines Market in Mexico (2021-2030)
• Figure 12: CRRT Machines Market in Europe (2021-2030)
• Figure 13: CRRT Machines Market in France (2021-2030)
• Figure 14: CRRT Machines Market in Germany (2021-2030)
• Figure 15: CRRT Machines Market in the United Kingdom (2021-2030)
• Figure 16: CRRT Machines Market in Italy (2021-2030)
• Figure 17: CRRT Machines Market in Spain (2021-2030)
• Figure 18: CRRT Machines Market in Rest of Europe (2021-2030)
• Figure 19: CRRT Machines Market in Asia-Pacific (2021-2030)
• Figure 20: CRRT Machines Market in China (2021-2030)
• Figure 21: CRRT Machines Market in Japan (2021-2030)
• Figure 22: CRRT Machines Market in India (2021-2030)
• Figure 23: CRRT Machines Market in Australia (2021-2030)
• Figure 24: CRRT Machines Market in South Korea (2021-2030)
• Figure 25: CRRT Machines Market in Rest of Asia-Pacific (2021-2030)
• Figure 26: CRRT Machines Market in the Rest of the World (2021-2030)
• Figure 27: CRRT Machines Market in the Middle East (2021-2030)
• Figure 28: CRRT Machines Market in Africa (2021-2030)
• Figure 29: CRRT Machines Market in South America (2021-2030)
• Figure 30: Market Drivers
• Figure 31: Market Barriers
• Figure 32: Market Opportunities
• Figure 33: PORTER's Five Force Analysis

Continuous Renal Replacement Therapy (CRRT) Machines Market By Product Type (Machines and Consumables), Modality (Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemodiafiltration (CVVHDF)), Patient (Adult And Pediatric), End-User (Hospitals, Dialysis Centres, and Others), and Geography is projected to grow at a constant CAGR during the forecast period from 2024-2030 on account of significant technological advancement and rising prevalence of acute renal failure.

Global Continuous Renal Replacement Therapy (CRRT) Machines Market was valued at USD 1.25 billion in 2023, growing at a CAGR of 7.39% during the forecast period from 2024 to 2030, to reach USD 1.92 billion by 2030. The demand for CRRT machines is predominantly attributed to the rise in the prevalence of acute renal failure or Acute Kidney Injury (AKI) across the globe, the growing burden of ICU patients with AKI along with an increase in the incidence of sepsis, significant technological advancements in the product line. The clinical advantage of CRRT over intermittent blood purification systems is also a prominent driving factor for the CRRT machines market.

CRRT Machines Market Dynamics:

Acute kidney injury (AKI) is one of the most common serious complications for all hospital admissions, with its incidence increasing among hospitalized patients, particularly those in the intensive care unit. Moreover, it is recognized that underlying chronic kidney disease is a risk factor for AKI. Also, according to a study published in LANCET 2020, in 2017, 697.5 million cases of all-stage CKD were recorded and around 1.2 million died from the indication. The rising prevalence of chronic kidney disorders and their associated deaths could have been reduced through proper and timely treatment through CRRT machines as these machines provide renal support by slowly removing fluid and uremic toxins and returning clean blood to the body over 24 hours duration in critically ill patients suffering from AKI and are hemodynamically unstable. Thus, contributing to the growth of the Global CRRT market.

Furthermore, various technological advancement which mainly comprises high permeability hemofiltration and high volume permeability since the advent of continuous renal replacement therapy is also expected to boost the global CRRT market.

At present, manufacturers are developing precise devices that are safe and give reliable performance during CRRT procedures. Also, for easy performance, these devices are equipped with a user-friendly interface. For instance, recently, in 2022, Baxter announced the launch of its latest version of the next-generation CRRT platform, PrisMax 2. The PrisMax 2 system features new solutions within the company's TrueVue digital health portfolio and is designed to help simplify the delivery of continuous renal replacement therapy (CRRT) and other organ support therapies while providing hospitals the flexibility to meet the unique demands of the intensive care unit (ICU). Thus, such factors are contributing to the upsurge of the global CRRT machines market.

However, certain factors such as the high procedural cost of CRRT are likely to pose a minor hurdle to the growth of the CRRT market.

CRRT Machines Market Segment Analysis:

CRRT Market By Product Type (Machines and Consumables), Modality (Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemodiafiltration (CVVHDF)), Patient (Adult and Pediatric), End-User (Hospitals, Dialysis Centres, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the CRRT market modality segment, Continuous Venovenous Hemofiltration (CVVH) holds the highest market. This is owing to the rising incidence of fluid overloads that are frequently found in patients with acute kidney injuries and in the ICU. However, it is also expected that Continuous Venovenous Hemodiafiltration (CVVHDF) will observe lucrative growth during the forecasted period. This is because the CVVHDF treatment modality results in the complete removal of solutes and fluids from the blood as it combines both the principle of convection and diffusion i.e., hemofiltration and hemodialysis by making use of a highly efficient hemofilter for the removal of solute and fluid. Thereby propelling the segmental growth of the CRRT market.

Moreover, most of CRRT machines are compatible with more than two or three modalities which can further fuel the market. In 2019, Baxter launched PrisMax system the company's platform for continuous renal replacement therapy (CRRT), therapeutic plasma exchange (TPE), and organ support therapies (OST). The system delivers all therapy modalities of CRRT and therapeutic plasma exchange (TPE) without additional equipment. Hence, these factors are responsible for the growth of the CVVH modality systems along with CVVHDF modalities during the forecasted period.

North America is expected to dominate the overall CRRT Machines Market:

Among all the regions, North America is expected to dominate the overall CRRT machines market during the forecast period. This domination is due to the growing demand for advanced technologies in CRRT machines, the increasing cases of CKD and associated AKIs in the region are driving regional growth.

Further, the United States represents the largest market worldwide supported by developed healthcare infrastructure and strong R&D expenditure by the key players. Rising product launch and commercialization agreements among the key manufacturers are also anticipated to boost the CRRT market. For instance, the recent launch of the first and only Pediatric and Neonatal Acute Dialysis Machine (Carpediem(TM) systems) in December 2020 which is intended to provide continuous renal replacement therapy (CRRT) to patients weighing between 2.5 and 10 kilograms in the United States is likely to grow the market in the region.

In addition, the integration of telehealth platforms to improve outcomes and the care experience for CKD patients deciding to treat at home is also expected to fuel the market in the region. For instance, in 2019, DaVita incorporated its connective technologies DaVita Care Connect into its home dialysis program to meet the latest COVID-19 regulations implemented by the government to prevent the transmission of infection.

Europe and Asia-Pacific region have the future potential growth for global CRRT machines. This is due to the increasing incidence and prevalence of AKI and rising government initiatives to increase awareness about the advancements in renal therapy which is likely to surge the market. According to the International Society of Nephrology 2022, every year, there are around 13.3 million cases of AKI and the burden is specifically high in emerging countries where the annual incidence is estimated to be 11.3 million.

Therefore, this situation is giving rise to a critical need for CRRT machines thereby augmenting the CRRT market in this region. Moreover, rapid urbanization, an increase in disposable income in emerging countries such as China, India, and others, and the presence of local manufacturers in the region are also projected to drive the global CRRT market.

CRRT Machines Market Key Players:

Some of the key market players operating in the CRRT machines market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, NIKKISO CO., LTD., B. Braun Melsungen AG, Asahi Kasei Corporation, Informed SA, Medtronic, and others.

Recent Developmental Activities in CRRT Machines Market:

In August 2020, Baxter obtained US FDA Emergency Use Authorization for Regiocit Replacement Solution used In CRRT.

In April 2020, Fresenius Medical Care received US FDA Emergency Use Authorization for multiFiltrate PRO System and multiBic/multiPlus Solutions to provide CRRT to treat patients in an acute care environment during the COVID-19 pandemic.

Key Takeaways from the CRRT Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the CRRT machines market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global CRRT machines Market.

Various opportunities available for the other competitor in the CRRT machines Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for CRRT Machines market growth in the coming future?

Target Audience who can be benefited from CRRT Machines Market Report Study

CRRT machines providers

Research organizations and consulting companies

CRRT machines-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in CRRT Machines

Various End-users who want to know more about the CRRT machines Market and latest technological developments in the CRRT machines market.

Frequently Asked Questions for CRRT Machines Market

What is CRRT Machine?

CRRT machines are used in blood purification therapy in patients suffering with acute renal failure or acute kidney injuries. The machine pumps and controls the rate of blood flow and includes software to safely monitor therapy delivery. These machines are available in four different modes: Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemodiafiltration (CVVHDF.

What are the drivers for the Global CRRT Machines Market?

The major factors fuelling the demand for CRRT machines are the rising prevalence of acute renal failure, the growing burden of acute kidney injuries among ICU patients, new product approvals, and the shifting focus of key players for developing advanced products.

What is the market for Global CRRT Machines?

Global Continuous Renal Replacement Therapy (CRRT) Machines Market was valued at USD 1.25 billion in 2023, growing at a CAGR of 7.39% during the forecast period from 2024 to 2030, to reach USD 1.92 billion by 2030.

What are the key players operating in the global CRRT Machines Market?

Some of the key market players operating in the CRRT machines market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, NIKKISO CO., LTD., B. Braun Melsungen AG, Asahi Kasei Corporation, Informed SA, Medtronic, and others.

What regions have the highest share in the CRRT Machines market?

North America is expected to dominate the overall CRRT Machines market during the forecast period, 2024 to 2030 due to the advanced healthcare system, increasing prevalence of chronic kidney disorders in the region, and rising product developmental activities among the key market players.

Table of Contents

1. CRRT Machines Market Report Introduction

2. CRRT Machines Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at a Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. CRRT Machines Market Key Factor Analysis

• 4.1 CRRT Machines Market Drivers
  • 4.1.1 Increasing Incidence of Acute Kidney Injury (AKI)
  • 4.1.2 Increasing Clinical Advantage of CRRT Over Intermittent Blood Purification
  • 4.1.3 Technological Advancement and New Product Launches
  • 4.1.4 Growing Number of ICU Patients with AKI
• 4.2 CRRT Machines Market Restraints and Challenges
  • 4.2.1 Stringent Regulatory Guidelines
  • 4.2.2 High Procedural Cost of CRRT
• 4.3 CRRT Machines Market Opportunities
  • 4.3.1 Development of CRRT Systems for Pediatric Patients
  • 4.3.2 Growth Opportunities in emerging countries

5. CRRT Machines Porter's Five Forces Analysis

• 5.1 Bargaining Power of Suppliers
• 5.2 Bargaining Power of Consumers
• 5.3 Threat of New Entrants
• 5.4 Threat of Substitutes
• 5.5 Competitive Rivalry

6. CRRT Machines Market layout

• 6.1 By Product Type
  • 6.1.1 Machines
  • 6.1.2 Consumables
• 6.2 By Modality
  • 6.2.1 Slow Continuous Ultrafiltration (SCUF)
  • 6.2.2 Continuous Venovenous Hemofiltration (CVVH)
  • 6.2.3 Continuous Venovenous Hemodialysis (CVVHD)
  • 6.2.4 Continuous Venovenous Hemodiafiltration (CVVHDF)
• 6.3 By Patient
  • 6.3.1 Adults
  • 6.3.2 Pediatrics
• 6.4 By End-User
  • 6.4.1 Hospitals
  • 6.4.2 Dialysis Centers
  • 6.4.3 Others
• 6.5 By Geography
  • 6.5.1 North America CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.1.1. United States CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.1.2. Canada CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.1.3. Mexico CRRT Machines Market Size in USD million (2021-2030)
  • 6.5.2 Europe CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.2.1 France CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.2.2 Germany CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.2.3 United Kingdom CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.2.4 Italy CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.2.5 Spain CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.2.6 Rest of Europe CRRT Machines Market Size in USD million (2021-2030)
  • 6.5.3 Asia-Pacific CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.3.1 China CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.3.2 Japan CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.3.3 India CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.3.4 Australia CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.3.5 South Korea CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.3.6 Rest of Asia-Pacific CRRT Machines Market Size in USD million (2021-2030)
  • 6.5.4 Rest of the World (RoW) CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.4.1 Middle East CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.4.2 Africa CRRT Machines Market Size in USD million (2021-2030)
    • 6.5.4.3 South America CRRT Machines Market Size in USD million (2021-2030)

7. CRRT Machines Company and Product Profiles

• 7.1 Baxter International Inc.
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2 Fresenius Medical Care AG & Co. KGaA
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3 NIKKISO CO., LTD.
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4 B. Braun Melsungen AG
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5 Asahi Kasei Corporation
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6 Infomed SA
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7 Medtronic
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8 NxStage Medical, Inc.
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9 Medica S.p.A.
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10 SWS Hemodialysis Care Co., Ltd.
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11 Dialco Medical Inc.
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12 Anjue Medical Equipment Co. Ltd.
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13 Medica S.p.A.
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14 Jiangxi Sanxin Medtec Co. Ltd.
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us